Skip to content
← Full study record

NCT00301756 · MORE INFO

Limitations, agreements, and source contact

Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors · Source last updated 2018-08-20

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
amit.oza@uhn.ca
organization
Princess Margaret Cancer Centre
phone
416-946-2818
title
Dr. Amit Oza
Complete source fields
certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
amit.oza@uhn.ca
organization
Princess Margaret Cancer Centre
phone
416-946-2818
title
Dr. Amit Oza

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice